Sun Pharma Q1 Results : Cons profit falls 20% YoY to Rs 2,278 crore, but revenue rises (...)
Sun Pharma Q1 Results FY26: Sun Pharmaceutical Industries reported a 20% fall in Q1 consolidated net profit, reaching Rs 2,278 crore. Despite this dip, revenue from operations increased by 10% to Rs 13,786 crore. Strong performance in the India market and growth in global innovative medicines (...)
Site référencé: The Economic Times
The Economic Times
Tata Investment Q1 Results : Cons PAT rises 12% YoY to Rs 146 crore, revenue up 2%
4/08/2025
India’s mutual fund industry clocks 7X growth in 10 years, equity funds garner Rs 86K crore in inflows : Motilal Oswal Mutual Fund (...)
4/08/2025
Sebi pushes for structural reforms in derivatives after Jane Street fallout : Report
4/08/2025
Adani Power shares rise 2% after board approves 1:5 stock split
4/08/2025
Reliance Power, Reliance Infra shares tumble 5% amid ED Probe into Rs 17,000 crore loan fraud
4/08/2025
ABB India shares tumble nearly 4% as Q2 profit slides 21% YoY
4/08/2025
